T&T Scientific was launched in 2015 by Dr. Nima Tamaddoni and Dr. Graham Taylor with the world's first fully assembled and disposable extrusion technologies and the great mission to provide a comprehensive range of high-quality products and services, with quick delivery to support your research, development, and manufacturing needs. Initially, T&T Scientific has raised close to $50,000 funds winning a series of business pitch competitions and within 6 months of launching started to generate revenue and within a year became profitable. T&T then scaled this technology up to automated equipment and started to demonstrate these technologies in academic institutions and pharmaceutical companies around the U. S. and then the globe. Within 5 years, today T&T has over 1,000 clients in over 50 countries around the globe, holding 12 patent-protected technologies, growing sales 10x year over year since start. T&T has distributor sales teams in 25 countries around the world who are covering the sales in over 40 countries.
Who We Are
What We Do?
T&T Scientific is home to the world’s most advanced and cutting-edge lipid nanoparticle technology. We provide pharmaceutical products and technologies for preparation and manufacturing of liposomes and lipid nanoparticles. We also offer a wide range GMP and non-GMP contract services for research and formulation development, analytical method and manufacturing process development, and supporting qualification and validation activities in our 15,000 sf state of the art facility and cleanroom spaces.
T&T Scientific is well equipped with the operational capabilities and Quality Assurance team required for clinical and commercial batch manufacturing of formulations utilized in therapeutics and vaccines. T&T is registered with the U.S. Food and Drug Administration (US-FDA) and is currently manufacturing lipid-based solutions intended for use in human clinical trials.
Our technologies include NanoSizer MINI, AUTO, and FLOW. These platforms represent the latest in extrusion and direct ethanol injection technologies for simple, scalable production of liposomes and lipid nanoparticles.
Our novel, proprietary formulation for gene therapy and transfection, ProFECT, is a patent protected, licensable formulation proven with pre-clinical in vitro data for safe and effective delivery of nucleic acids, such as RNA and DNA, for vaccine and therapeutic applications.
Why and How to Work with Us
T&T Scientific partners with pharmaceutical companies around the work to help as their contract research, development, and manufacturing organization. T&T helps clients with discovery, formulation development, analytical method development, manufacturing process development, as well as GMP and commercial manufacturing of the clinical and approved pharmaceutical therapeutics and vaccines.
T&T also help with complete technology transfer from institution/company to client's site or T&T facilities for scale up and continuation of development and manufacturing, processes.
Moreover, T&T Scientific offers latest technologies to be installed at client's facility for preparation, scale up, and manufacturing of lipid nanoparticles and liposomes.
Global Recognition with Clients Over 50 Countries
Global Recognition with Customers in over 50 Countries